Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Production & Manufacturing
Manufacturing
Return to: PBR Home | Production & Manufacturing | Manufacturing

Manufacturing

Novo Nordisk introduces hemophilia therapy Novoeight in US By PBR Staff Writer
Danish pharmaceutical firm Novo Nordisk has introduced Novoeight (Antihemophilic Factor [Recombinant]) in the US for the treatment of people living with hemophilia A.
Production & Manufacturing > Manufacturing > News
Akorn expands ophthalmic portfolio with Phenylephrine HCl ophthalmic solution launch By PBR Staff Writer
US-based specialty pharmaceutical firm Akorn has introduced Phenylephrine HCl Ophthalmic Solution, USP, 2.5% and 10% expanding its generic and branded ophthalmic portfolio.
Production & Manufacturing > Manufacturing > News Janssen Pharmaceuticals acquires ichorcumab developer XO1 Limited By PBR Staff Writer
Belgium-based Janssen Pharmaceuticals has acquired XO1 Limited, a privately held asset-centric virtual biopharmaceutical firm focused on developing the anti-thrombin antibody ichorcumab.
Production & Manufacturing > Manufacturing > News
See more Manufacturing news

Latest Manufacturing News and Insight

View all Manufacturing news or find news targeted to your interests
Sharp Clinical Services - Clinical Trials Supply Chain Services
We are a leading supplier of specialist clinical supply chain services, covering drug product development and manufacturing services, complex clinical supplies packaging, clinical labelling, as well as clinical distribution services.
Production & Manufacturing > Manufacturing > Suppliers
Janssen Pharmaceuticals acquires ichorcumab developer XO1 Limited
By PBR Staff Writer
Belgium-based Janssen Pharmaceuticals has acquired XO1 Limited, a privately held asset-centric virtual biopharmaceutical firm focused on developing the anti-thrombin antibody ichorcumab.
Production & Manufacturing > Manufacturing > News
ImmunoCellular, PharmaCell partner for European production of cancer immunotherapy ICT-107
By PBR Staff Writer
US-based ImmunoCellular Therapeutics has entered into an agreement with Dutch contract manufacturing organisation (CMO) PharmaCell to offer contract manufacturing services for the European production of a dendritic cell-based cancer immunotherapy, ICT-107, being developed as a potential treatment for glioblastoma (GBM).
Production & Manufacturing > Manufacturing > News
Upcoming Events
Find out more about Sharp Clinical Services upcoming events.
Production & Manufacturing > Manufacturing > Press Releases
Sharp EU Organisational Announcement
We recently announced a number of changes in our Sharp Packaging US business. I am delighted to be writing to you today to advise you of a number of important changes in our European Packaging business.
Production & Manufacturing > Manufacturing > Press Releases
Sharp Clinical Services ISO certification
Sharp Clinical Services UK is proud to announce its recent ISO 9001 and ISO 13485 certification following a successful audit by BSI.
Production & Manufacturing > Manufacturing > Press Releases
Scott Forde joins as Head of Business Development at UK site
Sharp Clinical Services, part of UDG Healthcare plc, has announced that Scott Forde has joined as Head of Business Development based at the Crickhowell site in South Wales.
Production & Manufacturing > Manufacturing > Press Releases
Frank Lis joins as President of Sharp Clinical Services
Sharp Packaging Services, part of UDG Healthcare plc, has announced that Frank Lis has joined as President of Sharp Clinical Services. In this role, Frank will have global responsibility for Sharp Clinical Services, which is the specialist clinical supply chain services business unit of the Sharp Packaging Services division of UDG Healthcare plc.
Production & Manufacturing > Manufacturing > Press Releases
Sharp Clinical Services Expand Their Deblistering Capabilities
Sharp Clinical Services Ltd. has expanded its' deblistering capabilities with the purchase of a STRIPFOIL Pharma de-blister machine.
Production & Manufacturing > Manufacturing > Press Releases
Actavis completes acquisition of Allergan for $70.5bn
By PBR Staff Writer
Irish pharmaceutical firm Actavis has completed the acquisition of US-based Botox maker Allergan in a cash-and-stock deal valued at about $70.5bn.
Production & Manufacturing > Manufacturing > News
View all Manufacturing news or find news targeted to your interests